Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Gridelli

Showing results (21-30 of 357) with videos related to

Pageof 36
Sort By:
Current Opinion in Oncology|February 3, 2007
Targeted therapies and non-small-cell lung cancer: new developmentsCesare Gridelli
Current Opinion in Oncology|June 18, 2009
Histology-based treatment: a new scenario in the management of advanced nonsmall cell lung cancerCesare Gridelli
Journal of Biomedicine & Biotechnology|January 6, 2012
Targeted therapies development in the treatment of advanced nonsmall cell lung cancerCesare Gridelli, Enriqueta Felip
Clinical Lung Cancer|February 18, 2004
Non-small-cell lung cancer in elderly patients: influence of age on vinorelbine oral pharmacokineticsChristian Puozzo, Cesare Gridelli
Expert Opinion on Emerging Drugs|May 5, 2023
Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?Francesca Casaluce, Cesare Gridelli
Translational Lung Cancer Research|February 2, 2019
The combination strategies will be ready the right first-line choice for squamous lung cancer patients?Cesare Gridelli, Francesca Casaluce
Journal of Thoracic Disease|July 11, 2022
Critical points in the management of <i>EGFR</i>-mutated non-small cell lung cancerFrancesca Casaluce, Cesare Gridelli
Expert Review of Anticancer Therapy|June 29, 2017
Recent advances in targeted advanced lung cancer therapy in the elderlyTania Losanno, Cesare Gridelli
Cancers|May 16, 2023
The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung CancerAlessia Spagnuolo, Cesare Gridelli
Translational Lung Cancer Research|January 5, 2018
The reproducibility of PD-L1 scoring in lung cancer: can the pathologists do better?Giancarlo Troncone, Cesare Gridelli
Pageof 36

Showing results (21-30 of 357) with videos related to

Sort By:
Pageof 36
Current Opinion in Oncology|February 3, 2007
Targeted therapies and non-small-cell lung cancer: new developmentsCesare Gridelli
Current Opinion in Oncology|June 18, 2009
Histology-based treatment: a new scenario in the management of advanced nonsmall cell lung cancerCesare Gridelli
Journal of Biomedicine & Biotechnology|January 6, 2012
Targeted therapies development in the treatment of advanced nonsmall cell lung cancerCesare Gridelli, Enriqueta Felip
Clinical Lung Cancer|February 18, 2004
Non-small-cell lung cancer in elderly patients: influence of age on vinorelbine oral pharmacokineticsChristian Puozzo, Cesare Gridelli
Expert Opinion on Emerging Drugs|May 5, 2023
Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?Francesca Casaluce, Cesare Gridelli
Translational Lung Cancer Research|February 2, 2019
The combination strategies will be ready the right first-line choice for squamous lung cancer patients?Cesare Gridelli, Francesca Casaluce
Journal of Thoracic Disease|July 11, 2022
Critical points in the management of <i>EGFR</i>-mutated non-small cell lung cancerFrancesca Casaluce, Cesare Gridelli
Expert Review of Anticancer Therapy|June 29, 2017
Recent advances in targeted advanced lung cancer therapy in the elderlyTania Losanno, Cesare Gridelli
Cancers|May 16, 2023
The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung CancerAlessia Spagnuolo, Cesare Gridelli
Translational Lung Cancer Research|January 5, 2018
The reproducibility of PD-L1 scoring in lung cancer: can the pathologists do better?Giancarlo Troncone, Cesare Gridelli
Pageof 36